SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

SEC Comment Letter 0000000000-23-006268 to Bright Green Corp (BGXX) (CIK 0001886799)

Bright Green Corp (BGXX) (CIK 0001886799)
Date: June 12, 2023 · CIK: 0001886799 · Accession: 0000000000-23-006268

AI Filing Summary & Sentiment

File numbers found in text: 333-272431

Date
June 12, 2023
Author
Not clearly detected
Form
UPLOAD
Company
Bright Green Corp (BGXX) (CIK 0001886799)

Letter

United States securities and exchange commission logo June 12, 2023 Seamus McAuley Chief Executive Officer Bright Green Corp 1033 George Hanosh Boulevard Grants, NM 87020 Re:Bright Green Corp Registration Statement on Form S-3 Filed June 5, 2023 File No. 333-272431 Dear Seamus McAuley: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jason Drory at 202-551-8342 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Grant Levine

Show Raw Text
United States securities and exchange commission logo
June 12, 2023
Seamus McAuley
Chief Executive Officer
Bright Green Corp
1033 George Hanosh Boulevard
Grants, NM 87020
Re:Bright Green Corp
Registration Statement on Form S-3
Filed June 5, 2023
File No. 333-272431
Dear Seamus McAuley:
            This is to advise you that we have not reviewed and will not review your registration
statement.
            Please refer to Rules 460 and 461 regarding requests for acceleration.  We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
            Please contact Jason Drory at 202-551-8342 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:       Grant Levine